Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC1 | Q13547 | 4/20 | 0.64 |
| ▸ | HDAC3 | O15379 | 3/20 | 0.64 |
| ▸ | HDAC2 | Q92769 | 3/20 | 0.64 |
| ▸ | HDAC8 | Q9BY41 | 3/20 | 0.64 |
| ▸ | HDAC6 | Q9UBN7 | 3/20 | 0.64 |
| ▸ | HDAC5 | Q9UQL6 | 3/20 | 0.64 |
| ▸ | HDAC4 | P56524 | 2/20 | 0.64 |
| ▸ | HDAC7 | Q8WUI4 | 2/20 | 0.64 |
| ▸ | HDAC10 | Q969S8 | 2/20 | 0.64 |
| ▸ | HDAC11 | Q96DB2 | 2/20 | 0.64 |
| ▸ | HDAC9 | Q9UKV0 | 2/20 | 0.64 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.64 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.64 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.64 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.64 |
| ▸ | PLAAT3 | P53816 | 6/20 | 0.59 |
| ▸ | PLAAT5 | Q96KN8 | 6/20 | 0.59 |
| ▸ | PLAAT2 | Q9NWW9 | 6/20 | 0.59 |
| ▸ | PLAAT4 | Q9UL19 | 6/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL108977 | 0.88 | ALDH1A1 (0.69) | HDAC1HDAC3HDAC2HDAC8HDAC6 | |
| SCHEMBL710419 | 0.83 | HDAC1 (0.69) | HDAC1HDAC3HDAC2HDAC8HDAC6 | |
| SCHEMBL5566614 | 0.83 | HDAC1 (0.69) | HDAC1HDAC3HDAC2HDAC8HDAC6 | |
| SCHEMBL110777 | 0.83 | ALDH1A1 (0.76) | HDAC1HDAC3HDAC2HDAC8HDAC6 | |
| SCHEMBL10571421 | 0.82 | HDAC1 (0.62) | HDAC1HDAC3HDAC2HDAC8HDAC6 | |
| Phenylbutanoic Acid SCHEMBL27883793 | 0.82 | HDAC1 (0.88) | HDAC1HDAC3HDAC2HDAC8HDAC6 | |
| Phenylbutanoic Acid SCHEMBL27900207 | 0.81 | HDAC1 (0.95) | HDAC1HDAC3HDAC2HDAC8HDAC6 | |
| SCHEMBL5020740 | 0.80 | ALDH1A1 (0.70) | HDAC1HDAC3HDAC2HDAC8HDAC6 | |
| SCHEMBL8640745 | 0.80 | HDAC1 (0.64) | HDAC1HDAC3HDAC2HDAC8HDAC6 | |
| SCHEMBL7640251 | 0.79 | PLAAT3 (0.58) | HDAC1HDAC3HDAC2HDAC8HDAC6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240315930-A1 | PASTE-FORM TWO-PACK TYPE DENTAL CURABLE COMPOSITION | KURARAY NORITAKE DENTAL INC. (JP) | 2024-09-26 | — | — | US | disclosed |
| EP-4413966-A1 | PASTE-FORM TWO-PART CURABLE COMPOSITION FOR DENTAL USE | Kuraray Noritake Dental Inc. (JP) | 2024-08-14 | — | — | EP | disclosed |
| CN-109879772-B | Benzylaminoyl derivative and application thereof in preparation of anti-inflammatory drugs | 中国科学院成都生物研究所 | 2022-03-29 | — | — | CN | disclosed |
| US-10758457-B2 | Curable composition and dental filling restorative material | TOKUYAMA DENTAL CORPORATION (JP) | 2020-09-01 | — | — | US | disclosed |
| EP-3369410-B1 | CURABLE COMPOSITION, CURABLE COMPOSITION FOR DENTAL USE, AND ORGANIC-INORGANIC COMPOSITE PARTICLES FOR DENTAL USE | TOKUYAMA DENTAL CORP (JP) | 2020-07-01 | — | — | EP | disclosed |
| US-10653586-B2 | Curable composition, curable composition for dental use, and organic-inorganic composite particles for dental use | TOKUYAMA DENTAL COOPERATION (JP) | 2020-05-19 | — | — | US | disclosed |
| US-20190038515-A1 | CURABLE COMPOSITION, CURABLE COMPOSITION FOR DENTAL USE, AND ORGANIC-INORGANIC COMPOSITE PARTICLES FOR DENTAL USE | TOKUYAMA DENTAL CORPORATION (JP) | 2019-02-07 | — | — | US | disclosed |
| US-20180303721-A1 | CURABLE COMPOSITION AND DENTAL FILLING RESTORATIVE MATERIAL | TOKUYAMA DENTAL CORPORATION (JP) | 2018-10-25 | — | — | US | disclosed |
| EP-3369410-A1 | CURABLE COMPOSITION, CURABLE COMPOSITION FOR DENTAL USE, AND ORGANIC-INORGANIC COMPOSITE PARTICLES FOR DENTAL USE | Tokuyama Dental Corporation (JP) | 2018-09-05 | — | — | EP | disclosed |
| EP-3366269-A1 | CURABLE COMPOSITION AND DENTAL FILLING RESTORATIVE MATERIAL | Tokuyama Dental Corporation (JP) | 2018-08-29 | — | — | EP | disclosed |
| US-9228035-B2 | Photo-curable nanoimprint composition, method for formatting pattern using the composition, and nanoimprint replica mold comprising cured product of the composition | TOKUYAMA CORPORATION (JP) | 2016-01-05 | — | — | US | disclosed |
| US-20060004107-A1 | Method for designing a pharmaceutical compound specific to a desired receptor, a designed compound thereby, and pharmaceutical compositions containing the same | OJIMA MASANORI | 2006-01-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240315930-A1 | PASTE-FORM TWO-PACK TYPE DENTAL CURABLE COMPOSITION | TIPRL, STAU1, CALCOCO2 | HDAC1 2697/4885HDAC3 3697/4885HDAC2 2291/4885 |
| US-20060004107-A1 | Method for designing a pharmaceutical compound specific to a desired receptor, a designed compound thereby, and pharmaceutical compositions containing the same | TBXA2R, PTAFR, PTGIR | HDAC1 4615/4885HDAC3 3623/4885HDAC2 4271/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.